Literature DB >> 4596060

N4-hydroxycytidine-a new mutagen of a base analogue type.

E Popowska, C Janion.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4596060     DOI： 10.1016/0006-291x(74)90864-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  7 in total

1.  The metabolism of N4-hydroxycytidine-a mutagen for Salmonella typhimurium.

Authors:  E Popowska; C Janion
Journal:  Nucleic Acids Res       Date:  1975-07       Impact factor: 16.971

2.  Strong and selective inhibitors of hepatitis B virus replication among novel N4-hydroxy- and 5-methyl-beta-L-deoxycytidine analogues.

Authors:  E Matthes; A Funk; I Krahn; K Gaertner; M von Janta-Lipinski; L Lin; H Will; H Sirma
Journal:  Antimicrob Agents Chemother       Date:  2007-04-02       Impact factor: 5.191

3.  2-(p-Nitrophenyl)-2'-deoxyadenosine, a new type of mutagenic nucleoside.

Authors:  A Matsuda; Y Ohara; T Kakutani; K Negishi; Y Wataya; H Hayatsu; T Ueda
Journal:  Nucleic Acids Res       Date:  1990-04-11       Impact factor: 16.971

4.  N4-aminocytidine, a nucleoside analog that has an exceptionally high mutagenic activity.

Authors:  K Negishi; C Harada; Y Ohara; K Oohara; N Nitta; H Hayatsu
Journal:  Nucleic Acids Res       Date:  1983-08-11       Impact factor: 16.971

5.  Cellular pharmacology of the anti-hepatitis B virus agent beta-L-2',3'-didehydro-2',3'-dideoxy-N4-hydroxycytidine: relevance for activation in HepG2 cells.

Authors:  E Matthes; H Bünger
Journal:  Antimicrob Agents Chemother       Date:  2009-11-16       Impact factor: 5.191

6.  Small-Molecule Antiviral β-d-N 4-Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance.

Authors:  Maria L Agostini; Andrea J Pruijssers; James D Chappell; Jennifer Gribble; Xiaotao Lu; Erica L Andres; Gregory R Bluemling; Mark A Lockwood; Timothy P Sheahan; Amy C Sims; Michael G Natchus; Manohar Saindane; Alexander A Kolykhalov; George R Painter; Ralph S Baric; Mark R Denison
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

Review 7.  Antiviral activity of molnupiravir against COVID-19: a schematic review of evidences.

Authors:  Shivali Singla; Sachin Goyal
Journal:  Bull Natl Res Cent       Date:  2022-03-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.